Last updated: 2026-09-09 19:42:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Lexicon Pharmaceuticals, Inc. (LXRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.15, with a market capitalization of $996.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.06 to $2.68. This page covers its latest market performance, valuation, price trends and company information.
$996.70M | |
$2.25 | |
$28.21 | |
$0.28 | |
$2.23 | |
1.48M | |
3.32M | |
-- | |
$2.68 | |
$1.06 | |
-- | |
-- |
Lexicon Pharmaceuticals, Inc. (LXRX) is currently trading at $2.15 as of 2026-09-09 19:26:33, down 3.81% ($0.08) from the previous close of $2.23
During today's regular trading session, LXRX has traded between $0.28 and $28.21, with a trading volume of 1.48M shares. The current price is near the lower end of today's range.
Over the past seven days, Lexicon Pharmaceuticals, Inc. (LXRX) moved from $2.29 to $2.15, representing a decline of 6.33% ($0.15).
The stock traded between $2.14 and $2.32 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.55 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 67.0%
LXRX is currently trading at $2.15, placing it 67.0% of the way from its 52-week low of $1.06 to its 52-week high of $2.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 81 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Lexicon Pharmaceuticals, Inc. (LXRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.